Enanta Pharmaceuticals | ENTA - EPS Earnings Per Share


Enanta Pharmaceuticals reported $-1.05 in EPS Earnings Per Share for its fiscal quarter ending in December of 2024.





Eps Change Date
AbbVie USD 3.65 1 Jun/2026
Amgen USD 6.29 1.14 Jun/2026
Anika Therapeutics USD 0.13 0.35 Dec/2025
Arrowhead Research USD -1.36 0.43 Jun/2026
AstraZeneca USD 2.63 0.05 Jun/2026
BioCryst Pharmaceuticals USD 0.3 0.87 Jun/2026
Biogen USD 3.6 0.03 Jun/2026
Bristol-Myers Squibb USD 2.04 0.46 Jun/2026
Enanta Pharmaceuticals USD -1.05 0.31 Dec/2024
Gilead Sciences USD -6.75 8.78 Jun/2026
GlaxoSmithKline GBP 0.51 0.08 Jun/2026
Halozyme Therapeutics USD 2.28 0.68 Jun/2026
Heron Therapeutics USD -0.02 0.02 Dec/2025
Immunic USD -0.1 0.03 Dec/2025
Incyte USD 3.09 1.28 Jun/2026
Insmed USD -0.06 0.7 Jun/2026
Ionis Pharmaceuticals USD -0.69 0.13 Jun/2026
J&J USD 2.9 0.2 Jun/2026
Karyopharm Therapeutics USD -1.02 1.2 Mar/2026
Ligand Pharmaceuticals USD 2.37 0.74 Jun/2026
Merck USD -0.13 1.15 Jun/2026
Neurocrine Biosciences USD 2.85 0.91 Jun/2026
Novartis USD 2.41 0.42 Jun/2026
Novavax USD 0.13 0.59 Dec/2025
Pfizer USD 0.77 0.02 Jun/2026
PTC Therapeutics USD 0.92 0.95 Jun/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sarepta Therapeutics USD 0.64 2.52 Jun/2026
Vertex Pharmaceuticals USD 4.73 0.26 Jun/2026